Medicine Description westabreath 500mcg
westabreath tablets to treat the symptoms of chronic obstructive pulmonary disease, as it contains the active ingredient Roflumilast, which is an anti-inflammatory substance as it prevents inflammation and thus reduces swelling of the lungs and improves the breathing process and is used in the treatment of cases of lung function failure
About westabreath Tablets
- Drug Category : Respiratory Diseases
- Drug classification : Phosphodiesterase enzyme inhibitor - 4
- Active ingredient : Roflumilast
- Indications : Treatment of symptoms of pulmonary embolism